Medicared For All Logo

Albert Musaffi MD in Atlantis, Florida

Home Florida Atlantis

Albert Musaffi MD has Cardiovascular Disease (cardiology) as his primary medical specialty. Their primary office is: 5401 S Congress Ave in Atlantis, Florida. There is an additional office location, for a total of two, for Albert Musaffi MD that can be viewed further down.

They're a part of the: Medical Specialists Of The Palm Beaches Inc medical group which has around 107 members. You can call their office at 561-967-5033 to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended New York University School Of Medicine and graduated in 1980 (around 44 years of experience). They are not listed as doing telehealth appointments, but this may have changed. It can't hurt to call and check. If anything it may encourage them to make them available if they are not currently.


Albert Musaffi MD Office Phone and Directions

Albert Musaffi MD
Medical Specialists Of The Palm Beaches Inc
5401 S Congress Ave
Atlantis, Florida 33462
561-967-5033


Patient Ratings
Please rate your experience with Albert Musaffi MD below to help others make a more informed decision. Thanks!
Current Rating: Loading...

Phone: 561-967-5033


Enter a starting address:


Healthcare Info for Albert Musaffi MD

Medical School: New York University School Of Medicine
Graduation Year: 1980
The Primary Medical Specialty for Albert Musaffi MD is listed as: Cardiovascular Disease (cardiology)
Credentials: MD
Additional Credentials:
Approximate Years of Experience: 44
PAC (PECOS ID)#: 1153329727
NPI #: 1619924446
NPI Created On: 05/27/2006
NPI Last Updated Listed as: 10/03/2007
Primary Taxonomy Code: 207RC0000X
License Number:
ME39358
Listed Gender: Male

Insurance, Services, Charges


Forms of insurance accepted by include, but are not limited to:

  • Humana
  • Blue Cross Blue Shield
  • Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English, Spanish.


Services and Procedures include:

  1. Routine ekg using at least 12 leads including interpretation and report
  2. Heart rhythm tracing, computer analysis, and interpretation of patient-triggered events greater than 24-hour ekg up to 30 days
  3. Heart rhythm tracing, computer analysis, physician prescribed transmission of patient-triggered events greater than 24-hour ekg up to 30 days
  4. Evaluation, testing, and programming adjustment of permanent dual lead pacemaker system with physician analysis, review, and report
  5. Remote evaluations of single, dual, or multiple lead pacemaker system with qualified health care professional analysis, review, and report, up to 90 days
  6. Remote evaluations of defibrillator up to 90 days with analysis, review and report
  7. Remote evaluations of single, dual, or multiple lead pacemaker system or implantable defibrillator system with technician review, support and distribution of results, up to 90 days
  8. Remote evaluations of implantable heart and blood vessel monitor system with qualified health care professional analysis, review, and report, up to 30 days
  9. Remote evaluations of heart rhythm monitor system implanted under skin with qualified health care professional analysis, review, and report, up to 30 days
  10. Ultrasound examination of heart including color-depicted blood flow rate, direction, and valve function
  11. New patient office or other outpatient visit, typically 45 minutes
  12. Established patient office or other outpatient visit, typically 15 minutes
  13. Established patient office or other outpatient, visit typically 25 minutes
  14. Established patient office or other outpatient, visit typically 40 minutes
  15. Physician telephone patient service, 11-20 minutes of medical discussion
  16. Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days
  17. Remote physiologic monitoring treatment management services, health care professional time in a calendar month requiring interactive communication with the patient/caregiver; first 20 minutes
  18. Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec

They took part in Medicare's Electronic Health Record Incentive Program which was designed to help move people over to electronic records and improve the systems that were already in place.
They took part in the Medicare Physician Quality Reporting System (PQRS).

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.


Payments Total: $15

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788490051

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Cardiovascular & Metabolism

Name of Drug #1: XARELTO

Open Associated Drug #1: 50458-580-30

Drug or Biological: Drug

Product Category #2: Cardiovascular & Metabolism

Name Of Drug #2:: INVOKANA

Associated Drug #2: 50458-140-30


Payments Total: $17

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788490053

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Cardiovascular & Metabolism

Name of Drug #1: XARELTO

Open Associated Drug #1: 50458-580-30

Drug or Biological: Drug

Product Category #2: Cardiovascular & Metabolism

Name Of Drug #2:: INVOKANA

Associated Drug #2: 50458-140-30


Payments Total: $16

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788490055

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Cardiovascular & Metabolism

Name of Drug #1: XARELTO

Open Associated Drug #1: 50458-580-30

Drug or Biological: Drug

Product Category #2: Cardiovascular & Metabolism

Name Of Drug #2:: INVOKANA

Associated Drug #2: 50458-140-30


Payments Total: $19

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 828520685

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Genetic Disease

Name of Drug #1: ONPATTRO

Open Associated Drug #1: 71336-1000-1


Payments Total: $18

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Record ID:: 783443001

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Cardiovascular

Name of Drug #1: ELIQUIS

Open Associated Drug #1: 0003-0894-31


Payments Total: $12

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Record ID:: 783443011

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Cardiovascular

Name of Drug #1: ELIQUIS

Open Associated Drug #1: 0003-0894-31


Payments Total: $22

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 813105237

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: CARDIOVASCULAR

Name of Drug #1: ENTRESTO

Open Associated Drug #1: 0078-0659-20


Payments Total: $5

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 813105241

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: CARDIOVASCULAR

Name of Drug #1: ENTRESTO

Open Associated Drug #1: 0078-0659-20


Payments Total: $15

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 813105245

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: CARDIOVASCULAR

Name of Drug #1: ENTRESTO

Open Associated Drug #1: 0078-0659-20


Payments Total: $25

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 813105261

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: CARDIOVASCULAR

Name of Drug #1: ENTRESTO

Open Associated Drug #1: 0078-0659-20


Additional Office Locations

1. Medical Specialists Of The Palm Beaches Inc
9868 S State Rd
Boynton Beach, FL 33472
7 Suite 325
Group Members: 107

Phone: 561-967-5033

Enter a starting address:


Cardiovascular Disease (cardiology) Professionals in Atlantis

180 John F Kennedy Dr
Atlantis, FL
Lawnwood Cardiovascular Surgery Llc

180 Jfk Dr
Atlantis, FL
Lawnwood Cardiovascular Surgery Llc

5301 S Congress Ave
Atlantis, FL
Lawnwood Cardiovascular Surgery Llc

180 John F Kennedy Dr
Atlantis, FL
Lawnwood Cardiovascular Surgery Llc

5301 S Congress Ave
Atlantis, FL
Accountable Care Hospitalist Group

5401 S Congress Ave
Atlantis, FL
Medical Specialists Of The Palm Beaches Inc

Providers in Medical Specialists Of The Palm Beaches Inc

1.Accamma Abraham

205 Jfk Dr
Atlantis Fl 33462-1151
Medical Specialists Of The Palm Beaches Inc
Internal Medicine

2.Chelsea Albanese

15300 S Jog Rd
Delray Beach Fl 33446-2166
Medical Specialists Of The Palm Beaches Inc
Internal Medicine

3.Andres Albornoz

3472 Forest Hill Blvd
Palm Springs Fl 33406-5684
Medical Specialists Of The Palm Beaches Inc
Internal Medicine

4.Razan Alif

10115 Forest Hill Blvd
Wellington Fl 33414-3104
Medical Specialists Of The Palm Beaches Inc
Internal Medicine

5.Daniel Amaez

5401 S Congress Ave
Atlantis Fl 33462-6636
Medical Specialists Of The Palm Beaches Inc
Cardiovascular Disease (cardiology)

6.Daniel Amaez

9868 S State Rd
Boynton Beach Fl 33472-4477
Medical Specialists Of The Palm Beaches Inc
Cardiovascular Disease (cardiology)

View all 107 members of Medical Specialists Of The Palm Beaches Inc medical group